IL109521A - 1,3-Di-substituted 8-tetrahydro-2-naphthyl xanthines as selective adnenosine receptor agents - Google Patents

1,3-Di-substituted 8-tetrahydro-2-naphthyl xanthines as selective adnenosine receptor agents

Info

Publication number
IL109521A
IL109521A IL10952194A IL10952194A IL109521A IL 109521 A IL109521 A IL 109521A IL 10952194 A IL10952194 A IL 10952194A IL 10952194 A IL10952194 A IL 10952194A IL 109521 A IL109521 A IL 109521A
Authority
IL
Israel
Prior art keywords
adnenosine
xanthines
tetrahydro
naphthyl
selective
Prior art date
Application number
IL10952194A
Other languages
English (en)
Other versions
IL109521A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL109521A0 publication Critical patent/IL109521A0/xx
Publication of IL109521A publication Critical patent/IL109521A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL10952194A 1993-05-06 1994-05-03 1,3-Di-substituted 8-tetrahydro-2-naphthyl xanthines as selective adnenosine receptor agents IL109521A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5852393A 1993-05-06 1993-05-06

Publications (2)

Publication Number Publication Date
IL109521A0 IL109521A0 (en) 1994-08-26
IL109521A true IL109521A (en) 1999-09-22

Family

ID=22017346

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10952194A IL109521A (en) 1993-05-06 1994-05-03 1,3-Di-substituted 8-tetrahydro-2-naphthyl xanthines as selective adnenosine receptor agents

Country Status (14)

Country Link
US (1) US5734052A (fi)
EP (1) EP0697020A1 (fi)
JP (1) JPH08509977A (fi)
CN (1) CN1043473C (fi)
AU (1) AU676323B2 (fi)
CA (1) CA2159989C (fi)
FI (1) FI955257A (fi)
HU (1) HUT72327A (fi)
IL (1) IL109521A (fi)
MX (1) MX9403382A (fi)
NO (1) NO954399L (fi)
NZ (1) NZ265790A (fi)
WO (1) WO1994026744A1 (fi)
ZA (1) ZA943015B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025362A (en) * 1998-08-31 2000-02-15 Fukunaga; Atsuo F. Uses of xanthine compounds
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
US8871751B2 (en) * 2008-01-18 2014-10-28 The Board Of Trustees Of The University Of Illinois Compositions and methods relating to nuclear hormone and steroid hormone receptors including inhibitors of estrogen receptor alpha-mediated gene expression and inhibition of breast cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
US5087827A (en) * 1991-02-11 1992-02-11 Tektronix, Inc. Variable voltage transition circuit
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents

Also Published As

Publication number Publication date
FI955257A0 (fi) 1995-11-02
CN1122599A (zh) 1996-05-15
NO954399L (no) 1996-01-08
CN1043473C (zh) 1999-05-26
ZA943015B (en) 1995-01-30
JPH08509977A (ja) 1996-10-22
NO954399D0 (no) 1995-11-03
FI955257A (fi) 1995-11-02
CA2159989C (en) 1994-11-24
IL109521A0 (en) 1994-08-26
AU676323B2 (en) 1997-03-06
US5734052A (en) 1998-03-31
NZ265790A (en) 1996-10-28
HUT72327A (en) 1996-04-29
HU9503154D0 (en) 1996-01-29
CA2159989A1 (en) 1994-11-24
WO1994026744A1 (en) 1994-11-24
MX9403382A (es) 1995-01-31
AU6703294A (en) 1994-12-12
EP0697020A1 (en) 1996-02-21

Similar Documents

Publication Publication Date Title
ZA942570B (en) 1,5 benzodiazepine derivatives
AP9400613A0 (en) 2,6-diaminopurine derivatives
HU9603525D0 (en) Vironectin receptor antagonists
ZA93375B (en) 1,5-benzodiazepine derivatives
HU9601789D0 (en) Pyrazolopyridine adenosine antagonists
AU6781194A (en) 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
HU913074D0 (en) Fibrinogenic receptor antagonists
HU9503067D0 (en) Endotheline receptor antagonists
EP0663839A4 (en) COMBINATIONS OF IBUPROFEN WITH A H2 ANTAGONIST.
GB8814278D0 (en) Angle-adjustable workpiece seat
AP9400657A0 (en) 1,5 benzodiazepine derivatives
HUT74084A (en) Improved soap bar
EP0449175A3 (en) Selective adenosine receptor agents
GB2282062B (en) Seat Unit
IL109521A (en) 1,3-Di-substituted 8-tetrahydro-2-naphthyl xanthines as selective adnenosine receptor agents
HU9301651D0 (en) Pyridyl-1,2,5-oxadiazole-carbonamide-2-oxide derivatives
IL106287A0 (en) Receptor derivatives
ZA934873B (en) Receptor derivatives
ZA945327B (en) Azalicyclooctane derivatives as anti-arrhythmic agents
GB9307026D0 (en) Receptor cloning
HU9402902D0 (en) 1,2-dihydro-2-oxo-3-methyl-sulfonyl-aminomethyl-pyridine derivatives
GB9212427D0 (en) Receptor cloning
CA72817S (en) Swing seat
CA72188S (en) Soap bar
GB2269112B (en) Swing seat

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.